FDA advisers back drug that can slow Alzheimer's
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers this week, setting the stage for the treatment's expected approval for people with mild…
A closely watched Alzheimer's drug from Eli Lilly won the backing of federal health advisers this week, setting the stage for the treatment's expected approval for people with mild…